Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT04689048
Overview
The spread of cancer to the brain is referred to as brain metastases. Brain metastases are a common complication of cancer. This study is being done to determine whether the use of a new imaging agent, 18F-fluciclovine, is able to detect which patients are responding to radiation therapy. In addition, this study will look at the changes of the treated brain metastases using this imaging agent over time.
Sponsor
Baptist Health South Florida
Phase
Phase 1
Contacts
Rupesh C Kotecha, MD (Principal Investigator)
rupeshk@baptisthealth.net
17865962000
Maria C Avendano
mariaave@baptisthealth.net
17865962000
ClinicalTrials.gov
NCT04689048Drug / Compound
Help us improve your experience